SleepRes Introduces V-Com, a Comfort Accessory to Soften CPAP Peak Inspiratory Flow
At SLEEP 2022, SleepRes LLC introduced the V-Com, a CPAP accessory that the company...
At SLEEP 2022, SleepRes LLC introduced the V-Com, a CPAP accessory that the company...
In patients with minor ischemic stroke, OSA has a significant negative effect on comprehension and perception, according to study findings published recently.
Neurostimulation for sleep apnea doesn’t have decades of patient data like CPAP, but Inspire and remedē’s 1- and 5-year outcome studies show sustained benefits.
A recent study conducted at the University of Eastern Finland investigated differences between sleep arousals caused by varying respiratory events.
New research from the American Heart Association revealed beta-blockers were not more likely to cause depression compared to other similar treatments, but the drugs may be linked to unusual dreams, insomnia and sleep disorders.
The FDA approved a new indication for Xywav for idiopathic hypersomnia, an uncommon chronic sleep disorder that causes people to be excessively sleepy during the day even after a good night's sleep.